Je koopt precies het boek dat op de foto staat
Meer over het boek
The book presents a groundbreaking strategy for complete cancer treatment through two novel drug compounds, PT162 and PT167, developed by Andreas J. Kesel. These drugs target the Warburg effect, exploiting cancer's reliance on glycolysis due to mitochondrial dysfunction. Both compounds demonstrate significant efficacy in vitro against 60 cancer cell lines, inducing apoptosis by reactivating p53 and disrupting cyclin D1 regulation. The book details the chemistry behind these compounds and their apoptotic mechanisms, offering hope for innovative cancer therapies.
Een boek kopen
THE POTENTIAL HEALING OF CANCER WITH P53 (RE)ACTIVATORS, Andreas Johannes Kesel
- Taal
- Jaar van publicatie
- 2023
- Bindwijze
- (Hardcover),
- Staat van het boek
- Zeer goed
- Prijs
- € 23,49
Betaalmethoden
Nog niemand heeft beoordeeld.
- Titel
- THE POTENTIAL HEALING OF CANCER WITH P53 (RE)ACTIVATORS
- Ondertitel
- TWO NEW DRUGS EXPLOITING CANCER'S WARBURG EFFECT
- Taal
- Engels
- Auteurs
- Andreas Johannes Kesel
- Uitgever
- tredition
- Jaar van publicatie
- 2023
- Formaat
- Hardcover
- Aantal pagina's
- 264
- ISBN10
- 3384003128
- ISBN13
- 9783384003126
- Reeks
- Categorieën
- Tags
- Non-fictie, Gezondheid & Medisch, Wetenschap en Wiskunde, Natuur, Natuurwetenschappen, Geneeskunde, Chemie, Farmacologie, Biochemie, Oncologie, Organische Chemie, Moleculaire biologie, Menselijke Biologie, Anorganische Chemie, Chemotherapie, Farmacotherapie
- Aantekening
- The book presents a groundbreaking strategy for complete cancer treatment through two novel drug compounds, PT162 and PT167, developed by Andreas J. Kesel. These drugs target the Warburg effect, exploiting cancer's reliance on glycolysis due to mitochondrial dysfunction. Both compounds demonstrate significant efficacy in vitro against 60 cancer cell lines, inducing apoptosis by reactivating p53 and disrupting cyclin D1 regulation. The book details the chemistry behind these compounds and their apoptotic mechanisms, offering hope for innovative cancer therapies.